Reading is good for you...
Reading about what's good for you is even better.
August 8, 2022
August 10, 2022
August 2, 2022
Get your Uromitexan delivered at your door for FREE
Uromitexan (Mesna) is used to protect the bladder against some of the harmful effects of certain cancer medications known as oxazaphosphorines (e. g.
Medication pricing not available right now.
Please message us or give us a call at 1-855-950-7225.
Uromitexan (Mesna) is used to protect the bladder against some of the harmful effects of certain cancer medications known as oxazaphosphorines (e.g., Cyclophosphamide, Ifosfamide). After injection, Uromitexan (Mesna) stays in the blood and is quickly moved to the kidney. Once in the kidney, it attaches to the by-products of cancer medications that can cause harm to the bladder, making them harmless.
Uromitexan (Mesna) may be available under multiple brand names and/or in several different forms. Any specific brand name of Uromitexan (Mesna) may not be available in all of the forms or approved for all of the conditions discussed here. As well, some forms of Uromitexan (Mesna) may not be used for all of the conditions discussed here.
Your doctor may have suggested Uromitexan (Mesna) for conditions other than those listed in these drug information articles. If you have not discussed this with your doctor or are not sure why you are being given Uromitexan (Mesna), speak to your doctor. Do not stop taking Uromitexan (Mesna) without consulting your doctor.
Uromitexan (Mesna) is injected into a vein through a specially prepared site on your skin. The recommended dose is usually 20% of the dose of cyclophosphamide. The injection is given at the time of a cyclophosphamide dose injection, then 4 and 8 hours later.
In the case of ifosfamide, the recommended dose is 10 mg to 12 mg per kilogram of body weight at the time of the ifosfamide dose, and 4 and 8 hours later.
Uromitexan (Mesna) may also be given by mouth under certain circumstances. When this is the case, the dose may be higher than those suggested here.
Uromitexan (Mesna) may also be given to people being prepared for bone marrow transplantations. Under these circumstances, the doses may be given around the clock for a brief period of time.
Many things can affect the dose and schedule of medication that a person needs, such as body size, other medical conditions, and other medications. Your doctor may choose a different dose or schedule than the ones listed here. Uromitexan (Mesna) is always given under the direct supervision of your doctor.
Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.
Many medications can cause side effects. A side effect is an unwanted response to a medication when it is taken in normal doses. Side effects can be mild or severe, temporary or permanent. The side effects listed below are not experienced by everyone who takes Uromitexan (Mesna). If you are concerned about side effects, discuss the risks and benefits of Uromitexan (Mesna) with your doctor.
The following side effects have been reported by at least 1% of people taking Uromitexan (Mesna). Many of these side effects can be managed, and some may go away on their own over time.
Contact your doctor if you experience these side effects and they are severe or bothersome. Your pharmacist may be able to advise you on managing side effects.
Although most of these side effects listed below don't happen very often, they could lead to serious problems if you do not check with your doctor or seek medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Stop taking the medication and seek immediate medical attention if any of the following occur:
Some people may experience side effects other than those listed. Check with your doctor if you notice any symptom that worries you while you are taking Uromitexan (Mesna).
Each mL of solution contains Uromitexan (Mesna) 100 mg. Nonmedicinal ingredients: disodium edetate, sodium hydroxide (for pH adjustments), and sterile water for injection.
Each mL of solution contains 100 mg of Uromitexan (Mesna). Nonmedicinal ingredients: disodium edetate, sodium hydroxide, sterile water for injection, and benzyl alcohol (104 mg in the 10 mL vial; 520 mg in the 50 mL vial) as a preservative.
Uromitexan (Mesna) should not be used by anyone who is allergic to Uromitexan (Mesna) or to any of the ingredients of the medication.
Tell your doctor or prescriber about all prescription, over-the-counter (non-prescription), and herbal medications that you are taking. Also tell them about any supplements you take. Since caffeine, alcohol, the Nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them. Depending on your specific circumstances, your doctor may want you to:
An interaction between two medications does not always mean that you must stop taking one of them. In many cases, interactions are intended or are managed by close monitoring. Speak to your doctor about how any drug interactions are being managed or should be managed.
Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Uromitexan (Mesna).
Drowsiness/reduced alertness: Uromitexan (Mesna) may cause drowsiness or dizziness, affecting your ability to drive or operate machinery. Avoid driving, operating machinery, or performing other potentially hazardous tasks until you have determined how Uromitexan (Mesna) affects you.
Tests for ketones in urine: Uromitexan (Mesna) may cause tests for ketones in the urine to be falsely positive.
Pregnancy: Uromitexan (Mesna) should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking Uromitexan (Mesna), contact your doctor immediately. Because the use of oxazaphosphorines is not recommended during pregnancy, pregnant women should not need to take Uromitexan (Mesna).
Breast-feeding: It is not known if Uromitexan (Mesna) passes into breast milk. If you are a breast-feeding mother and are taking Uromitexan (Mesna), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
All material © 1996-2021 MediResource Inc. Terms and conditions of use. The contents herein are for informational purposes only. Always seek the advice of your physician or other qualified health providers with any questions you may have regarding a medical condition.
August 8, 2022
August 10, 2022
August 2, 2022